vs
Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $3.9M, roughly 1.5× Opus Genetics, Inc.). On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -12.7%).
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
CVR vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.0M | $3.9M |
| Net Profit | $-1.2M | — |
| Gross Margin | 2.7% | — |
| Operating Margin | -15.3% | — |
| Net Margin | -19.3% | — |
| Revenue YoY | 45.9% | -10.2% |
| Net Profit YoY | 68.0% | 53.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.0M | $3.9M | ||
| Q3 25 | $7.4M | $3.1M | ||
| Q2 25 | $7.3M | $2.9M | ||
| Q1 25 | $7.2M | $4.4M | ||
| Q4 24 | $4.1M | $4.3M | ||
| Q3 24 | $7.0M | $3.9M | ||
| Q2 24 | $8.1M | $1.1M | ||
| Q1 24 | $7.9M | $1.7M |
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $67.6K | $-17.5M | ||
| Q2 25 | $-395.0K | $-7.4M | ||
| Q1 25 | $401.0K | $-8.2M | ||
| Q4 24 | $-3.6M | — | ||
| Q3 24 | $-1.4M | $-7.5M | ||
| Q2 24 | $142.1K | $-7.8M | ||
| Q1 24 | $-698.0K | $-7.1M |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 22.9% | — | ||
| Q4 24 | -43.7% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 17.6% | — | ||
| Q1 24 | 9.5% | — |
| Q4 25 | -15.3% | — | ||
| Q3 25 | 0.9% | -269.9% | ||
| Q2 25 | -5.7% | -309.0% | ||
| Q1 25 | 1.0% | -227.2% | ||
| Q4 24 | -86.4% | — | ||
| Q3 24 | -11.8% | -207.1% | ||
| Q2 24 | 1.3% | -748.9% | ||
| Q1 24 | -11.5% | -450.5% |
| Q4 25 | -19.3% | — | ||
| Q3 25 | 0.9% | -566.9% | ||
| Q2 25 | -5.4% | -257.5% | ||
| Q1 25 | 5.5% | -187.5% | ||
| Q4 24 | -88.0% | — | ||
| Q3 24 | -20.8% | -194.6% | ||
| Q2 24 | 1.8% | -698.3% | ||
| Q1 24 | -8.9% | -415.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.25 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.8M | $15.3M |
| Total Assets | $23.3M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $45.1M | ||
| Q3 25 | $1.7M | $30.8M | ||
| Q2 25 | $1.2M | $32.4M | ||
| Q1 25 | $765.6K | $41.8M | ||
| Q4 24 | $2.2M | $30.3M | ||
| Q3 24 | $2.2M | $36.6M | ||
| Q2 24 | $2.6M | $41.4M | ||
| Q1 24 | $2.7M | $47.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.8M | $15.3M | ||
| Q3 25 | $20.0M | $6.0M | ||
| Q2 25 | $20.0M | $17.5M | ||
| Q1 25 | $20.4M | $5.1M | ||
| Q4 24 | $20.0M | $6.7M | ||
| Q3 24 | $23.7M | $34.3M | ||
| Q2 24 | $25.2M | $40.6M | ||
| Q1 24 | $25.2M | $46.1M |
| Q4 25 | $23.3M | $50.2M | ||
| Q3 25 | $24.0M | $36.1M | ||
| Q2 25 | $23.6M | $38.7M | ||
| Q1 25 | $24.1M | $48.2M | ||
| Q4 24 | $23.4M | $36.9M | ||
| Q3 24 | $26.4M | $40.4M | ||
| Q2 24 | $27.3M | $44.8M | ||
| Q1 24 | $27.8M | $51.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $116.4K | $-35.3M |
| Free Cash FlowOCF − Capex | $24.3K | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.4K | $-35.3M | ||
| Q3 25 | $638.0K | $-6.2M | ||
| Q2 25 | $28.2K | $-10.3M | ||
| Q1 25 | $-2.0M | $-9.0M | ||
| Q4 24 | $-60.1K | $-25.6M | ||
| Q3 24 | $-58.2K | $-5.1M | ||
| Q2 24 | $363.5K | $-7.3M | ||
| Q1 24 | $-398.8K | $-5.7M |
| Q4 25 | $24.3K | — | ||
| Q3 25 | $492.1K | — | ||
| Q2 25 | $-22.8K | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-118.1K | — | ||
| Q3 24 | $-368.9K | — | ||
| Q2 24 | $58.0K | — | ||
| Q1 24 | $-491.8K | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | -28.3% | — | ||
| Q4 24 | -2.9% | — | ||
| Q3 24 | -5.3% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -6.3% | — |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.8% | — | ||
| Q1 24 | 1.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
IRD
Segment breakdown not available.
